Treace Medical Concepts, Inc. (TMCI)
| Market Cap | 1.28B |
| Revenue (ttm) | 77.73M |
| Net Income (ttm) | n/a |
| Shares Out | 49.19M |
| EPS (ttm) | -0.26 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 113,794 |
| Open | 24.50 |
| Previous Close | 24.45 |
| Day's Range | 22.87 - 24.76 |
| 52-Week Range | 22.43 - 37.17 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | Nov 4, 2021 |
About TMCI
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of device and/or biologic solutions for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil os...
Financial Performance
In 2020, TMCI's revenue was $57.37 million, an increase of 45.54% compared to the previous year's $39.42 million. Losses were -$3.67 million, -14.00% less than in 2019.
Financial StatementsNews
Treace to Report Third Quarter 2021 Financial Results on November 4, 2021
PONTE VEDRA, Fla., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surg...
Treace Announces New ALIGN3D™ Data at the 2021 AOFAS Annual Meeting
PONTE VEDRA, Fla., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...
Treace Announces Launch of Adductoplasty™ Instrumented Midfoot Correction System
PONTE VEDRA, Fla., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...
Treace Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference
PONTE VEDRA, Fla., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...
Treace Announces New Supportive ALIGN3D™ Data to be Presented at the 2021 AOFAS Annual Meeting
PONTE VEDRA, Fla., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...
Treace Medical Concepts Reports Second Quarter 2021 Financial Results
PONTE VEDRA, Fla., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm ...
Treace to Report Second Quarter 2021 Financial Results on August 5, 2021
PONTE VEDRA, Fla., July 27, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surg...
Treace Medical Concepts Reports First Quarter 2021 Financial Results
PONTE VEDRA, Fla., May 25, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm s...
Treace Medical's Lapiplasty 3D Associated With Early Weightbearing After Foot Surgery, Interim Data Shows
Medical device company Treace Medical Concepts Inc (NASDAQ: TMCI) has announced interim results from the ALIGN3D clinical study, a post-market 5-year study designed to evaluate outcomes of Lapiplasty 3D...
Treace Announces Interim Results from ALIGN3D™ Clinical Study at ACFAS 2021
PONTE VEDRA, Fla., May 19, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgica...
Treace to Report First Quarter 2021 Financial Results on May 25, 2021
PONTE VEDRA, Fla., May 18, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...
Treace to Announce Interim Results from ALIGN3D™ at ACFAS 2021
PONTE VEDRA, Fla., May 12, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgica...
UPDATE - Treace Medical Concepts Announces Pricing of Upsized Initial Public Offering
PONTE VEDRA, Fla., April 22, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...
Treace Medical Concepts Announces Pricing of Upsized Initial Public Offering
PONTE VEDRA, Fla., April 22, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgi...
Treace Medical Concepts expects to raise $90.2 million in IPO
Ponte Vedra-based company plans to reach the market this week.
Treace Medical Concepts IPO Registration Document (S-1)
Treace Medical Concepts, Inc. has filed to go public with an IPO on the NASDAQ.